CLINICAL_TRIALS
trial_result
· 2012-02-24
Clinical Trial Update: Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke （Japan Alteplase Clinical Trial Ⅱ：J-ACT Ⅱ） [Phase 4]
Summary
Post-marketing Phase 4 study of alteplase for acute ischemic stroke in Japan (J-ACT II) has completed and results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tanabe Pharma Corporation | Conditions: Stroke | Phase 4 | Status: COMPLETED | Results posted: 2012-02-24